NightHawk Ecosystem Subsidiaries

Skunkworx Bio is trailblazing a new era of precision medicine where biology drives innovation. Our approach utilizes “Pocket Biologics” derived from diverse proprietary antibody and small protein libraries to identify and differentiate pharmacologically active “HotSpot” sites on proteins relevant to disease. Coupled with the integration of computational and bioinformatic analysis, the goal is to improve candidate selection and accelerate validation of innovative therapeutics from discovery into preclinical development.

Elusys Therapeutics is a NightHawk company that develops and commercializes novel therapies to combat infectious disease. Our anthrax antitoxin, ANTHIM® (obiltoxaximab) is approved in the United States, Canada, the United Kingdom, and the European Union as a medical countermeasure to mitigate the effect of anthrax exposure after a natural incident or intentional attack. We are committed to the deployment of innovated biodefense products to defend tomorrow today.

Scorpius Biological Services is an integrated contract research and development biomanufacturing organization (CDMO) focused on cell- and gene-based therapies and large molecule biologics. Scorpius provides a broad array of biologics manufacturing, as well as analytical and R&D services to NightHawk and external partners, with a focus on offering services using American-made equipment, reagents, and materials. Scorpius couples cGMP biomanufacturing and quality control expertise with cutting edge capabilities in immunoassays, molecular assays, and bioanalytical methods to realize the potential of our discoveries.